Martinez-Cuadron D, Sobas M, Vellenga E, et al. Incidence and risk factors for early death among 2421 APL patients: the Pethema registry experience. 24th Congress of EHA, abstract PF255.
Lebrikizumab en melfalan flufenamide in de sluis geplaatst
dec 2023 | Eczeem, MM